Skip to main content

Biechele Royce Advisors

SEC CIK
0001730808
Latest filing
Oct 29, 2024

DNA holding history

Ginkgo Bioworks Holdings, Inc. in every 13F filed by Biechele Royce Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNA overviewAll 13F holders of DNAFull Q3 2024 holdings

Shares (Q4 2022)
0
Sold out in Q4 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q3 2022
Holdings of DNA by Biechele Royce Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20220$00.0%−70,399−100.0%Sold outHolders
Q3 202270,399$219.0K0.1%+70,399NewHolders